The distribution and clearance of viral RNA (vRNA) and mRNA has been analysed for the acute and recovery stages of the pneumonia induced by intranasal infection of C57BL/6J mice with H3N2 influenza A viruses. Amplification of viral genomic material by the polymerase chain reaction showed that the influenza haemagglutinin (HA) gene was eliminated from the lungs of immunologically intact mice by day 14 postinfection, whereas in vitro depletion of the CD4 + T cells delayed clearance by at most 4 days. Viral RNA encoding the HA gene was first demonstrated in the regional mediastinal lymph nodes at 48 h, and continued to be present until day 6 or day 10 after infection of the intact and CD4-depleted mice, respectively. Evidence for the presence of vRNA in the thymus, but not in the mesenteric lymph nodes or the spleen, was found in some situations. Otherwise, the distribution and clearance of vRNA was as would be predicted from earlier studies using virus isolation procedures to monitor localization patterns, and shows a lack of long-term persistence of the influenza virus genome.
Analysis of the murine influenza model has shown that the elimination of the CD4 ÷ T cell population by treatment with subset-specific monoclonal antibodies (MAbs) makes no obvious difference to maximal virus titres in lung and delays the elimination of infectious virus by at most a few days (Allan et aL, 1990) . However, failure to isolate virus during an immune response cannot be taken as definitive evidence that the agent has indeed been cleared from an infected organ. The possibility exists that specific antibody present in tissue fluids, or in B cells/plasma cells that have localized to the site of pathology, may neutralize residual virus that is exposed when the tissue is homogenized. The presence of such bound antibody should not, however, inhibit the detection of viral RNA by the polymerase chain reaction (PCR) amplification. We have thus used this approach to analyse the persistence of influenza virus genome in the lung and regional mediastinal lymph nodes (MLN) of intranasally (i.n.) infected, intact and CD4-depleted mice.
The mouse-adapted (Kilbourne, 1969; Katz & Webster, 1988 ) H3N2 influenza A viruses HKx31 and A/Mem/6/86 (H3N2/86) were grown in the allantoic cavity of embryonated chicken eggs. Female C57BL/6 (B6) mice (Jackson Laboratories) were anaesthetized with 'Avertin' (2,2,2-tribromoethanol) prior to i.n. infection with 1 haemagglutination unit (HAU) of H3N2/86 or 100 HAU of HKx31 in 30 ~tl of PBS. A group of mice was depleted of CD4 ÷ T cells by treatment with the Gk 1.5 MAb (Dialynas et al., 1983; Allan et al., 1990) . The MAbs was given 3 days prior to, at the time of, and 3 days after administration of virus, and then continued at 2-day intervals. The effectiveness of the treatment was checked by flow cytometry using a noncross-reacting MAb, as described previously (Lynch et al., 1989; Allan et al., 1990) .
Blood for serum antibody titration (Fazekas de St Groth & Webster, 1966) was obtained by cardiac puncture of anaesthetized mice. The MLN, thymus, lung, spleen and mesenteric lymph nodes were removed sequentially and stored at -70 °C. The dissection instruments were washed in 1 M-NaOH between samples to avoid cross-contamination with viral genomic material. Tissues from six mice were pooled and homogenized using disposable pellet mixers (Kontes). Approximately 10 mg of homogenate was digested with 0-04% proteinase K for 10 rain at room temperature. After treatment with 1% SDS, the protein was extracted three times with phenol and the nucleic acids were precipitated with ethanol.
To determine the presence of viral RNA (vRNA) by PCR, cDNA was synthesized by reverse transcriptase 0001-0154 © 1991 SGM (Life Sciences) using 100 pmol of a universal primer, PU12 (5' AGCAAAAGCAGG 3'), complementary to the common 3' terminus of influenza virus RNA segments. To determine the presence of HA-specific mRNA, the primer 686.2 (5' TCACAATGA-GGGTCTCCCA 3"), complementary to a region within the HA mRNA, was extended. After phenol extraction and ethanol precipitation, the PCR reaction was set up using 100 pmol of the haemagglutinin gene (HA)-specific primers 686.1 (5' GAGCTGGTTCAGAGTTCCTC 3') and 686.2, 1.5 mM of each dNTP, 2.5 units of native Taq polymerase (Perkin Elmer Cetus) in 50 mM-KCI, 10 mMTris-HCl pH 8.3, 1.5 mM-MgCI2 and 0-01 ~o gelatin. The reaction mixtures were overlaid with mineral oil and the tubes placed in a D N A Thermal Cycler (Perkin Elmer Cetus) for 40 cycles of denaturation (2 min at 94 °C), annealing (2 min at 37 °C) and extension (3 rain at 72 °C). The primers 686.1 and 686.2 are complementary to the HA gene of H3N2/86; although there are base changes in the complementary HKx31 HA sequence (two in 686.1 and one in 686.2; Gething et al., 1980) , these reaction conditions worked equally well for both strains. The presence of HA-specific cDNA resulted in the amplification of a 120 bp fragment. The samples were transferred from beneath the oil layer to a new tube and extracted twice with phenol. A sample volume (5 ~tl) was electrophoresed on a 3~o Nusieve/l~o Seakem agarose (FMC) gel at 100 V for 1.5 h. The D N A was then blotted onto nylon membranes (GeneScreen; Du Pont) and prehybridized for 30 rain in 1 ~ SDS, 1 M-NaCI, 10~ dextran sulphate and 100 Ixg/ ml denatured salmon sperm DNA. An H3N2/86 HA-specific oligomer, 686.3 (5' AGTCCTCACC-GAATCCTTGATGGAAAAAAC 3') was end-labelled with [7-32p]ATP and polynucleotide kinase and separated from unincorporated ATP on a NACS PREPAC column (Bethesda Research Laboratories). This probe was added to the prehybridization solution at 1 × 105 d.p.m./ml and the hybridization performed at 42 °C overnight. The blots were then washed twice in 2 × 1.5 M-NaC1, 0.15 M-sodium citrate (SSC) for 5 min each, and twice for 30 min in 2 x SSC, 1 ~o SDS. The latter wash was done at 60 °C for the H3N2/86 strain but at 42 °C for HKx31 since the HA gene of the latter virus has two mismatches in the sequence complementary to the probe. The autoradiographs were over-exposed to ensure that any faint bands were examined.
The sensitivity of the PCR under the sampling conditions used was established by logarithmic titration of H3N2/86 virus in lung homogenates from uninfected mice or in 100 mM-NaCI, 50 mM-Tris-HC1 pH 7.6, 1 mM-EDTA containing 10 I~g of yeast tRNA (Boehringer Mannheim). After extraction of RNA, cDNA was synthesized using the influenza virus-specific universal primer. The last 10-fold dilution of virus that could consistently be detected by amplification of the 120 bp HA fragment was equivalent to 5 x 10 -4 Ixl of stock allantoic fluid containing virus. When this virus stock was titrated in eggs, the dilution at which 50% of eggs showed virus growth (EIDso) contained 50 times less than that required for PCR. The distribution of vRNA at different times after infection with the H3N2/86 virus is summarized in Fig. 1 for lung, MLN and thymus from both immunologically intact and CD4-depleted mice. In intact mice the H3N2/86 influenza virus vRNA was eliminated from the lung by day 14, and from the MLN by day 8. Virus clearance was delayed in the CD4-depleted mice, with vRNA being cleared from the lung and the MLN by day 18 and day 14, respectively. Also, vRNA was demonstrated in the thymus of CD4-depleted, but not intact, mice for as long as 8 days post-infection. The presence of these relatively faint bands (Fig. 1) could reflect localization of virus to the thymus, or contamination of the tissue sample with the small, closely-associated lymph nodes. However vRNA was not found in the mesenteric lymph nodes or spleen at any stage, so the viral HA gene detected in the thymus was not a consequence of virus being present in the blood perfusing the organ. This absence of demonstrable viraemic dissemination of the virus was not modified by the greatly diminished antibody response of the CD4-depleted mice (Fig. 2) .
Evidence of virus replication was found for the H3N2/86 virus in the lung, with m R N A for the HA being demonstrated until day 6 or day 8 in the intact and CD4-depleted mice, respectively. At the time points tested (days 6, 8, 10, 14 and 18 post-infection) viral mRNA could not be detected in any sample of MLN, thymus, mesenteric lymph node or spleen of intact or CD4-depleted mice that were infected with H3N2/86.
The distribution of virus in intact mice was also tested for the HKx31 virus. Infectious HKx31 virus, vRNA and mRNA were shown to be present in the lung, MLN and thymus on day 4, but were otherwise confined to the lung at the time points tested. In the lung, PCR analysis showed vRNA present up to day 9, and mRNA up to day 7, post-infection. Inoculation of eggs resulted in growth of virus from lung homogenates (five lungs/ml) at 4 (107 EIDso/ml), 7 (105 EIDso/ml) and 8 (10 *.5 EIDs0/ml) days post-infection. No viral products were found at any stage in the spleen or mesenteric lymph nodes. The vRNA and mRNA detected in the thymus on day 4 was probably due to the presence of infected cells in the tissue, as care was taken to remove only the tip of the organ to minimize possible contamination with the adjacent lymph nodes.
The early events in the MLN were examined more closely, as i.n. infection with H3N2 influenza A viruses causes a substantial increase in the cellularity of this regional lymphoid tissue within 3 days (Allan et al., 1990) . The MLN were thus sampled at 8, 12, 24 and 48 h after i.n. infection with the H3N2/86 virus. However PCR did not show the presence of HA vRNA until 48 h after infection (data not shown). This delay could be explained by a requirement for growth of new virus in the lung epithelium, perhaps with associated damage to the respiratory basement membrane or the establishment of inflammation. Virus may then be transported to the MLN via lymph draining from the infected lung, either in free form or associated with monocytes or dendritic cells. If the presence of vRNA in the MLN indeed parallels the localization of viral protein to the lymph node, then the time from antigen exposure to development of a primary T cell response to an infectious influenza A virus is as short as 3 or 4 days (Bennink et al., 1978; Allan et al., 1990) . This lag phase could, of course, be less if the initial contact between T cell precursor and antigen-presenting ceils occurs in the bronchusassociated lymphoid tissue.
Thus the findings from the present PCR analysis of vRNA and mRNA are in general agreement with the overall paradigm developed from virus isolation studies (Ada & Jones, 1986; Allan et al., 1990) , that infectious influenza virus is effectively eliminated from both normal and CD4-depleted mice. A similar approach has been used to show clearance of an avian influenza virus from ducks (Wang & Webster, 1990 ), and to demonstrate virus in nasal washings from human patients (Bressoud et al., 1990) . The almost exclusive presence of replicating influenza virus in the mouse lung following i.n. exposure is in accord with earlier findings that most influenza virus is normally produced in the mammalian respiratory tract, and that viraemia does not usually occur. However, the PCR analysis shows quite clearly that viral genomic material does localize t o regional lymphoid tissue, even under conditions in which little infectious virus is found at this site. Although it is known that the influenza virus genome can be retained in cells in vitro for up to 5 weeks (Cane & Dimmock, 1990 ), our PCR analysis shows the effective clearance of all infected cells in mice and that vRNA does not persist in, for instance, long-lived macrophages or dendritic cells in either the lung or the regional lymph node. The possibility that otherwise cryptic reactivation of vRNA may contribute to the continued presence of antigen that is considered by some (Gray & Skarvall, 1988) to be important for the maintenance of immune memory is not supported by these experiments, although the current study does not address the question of long-term survival of protein from the initial infection as has been suggested by Astry et al. (1984) .
